Strategic Exit Paths for C-Corp MSOs: A Transaction-Time Diligence Framework

TECHNICAL BRIEF · M&A AND EXIT

A structural map of the five principal exit paths available to a closely held C-corporation Management Services Organization — § 1202 exclusion, § 1045 rollover, stock sale with § 338(h)(10) or § 336(e) election, § 368 reorganization, and § 331 liquidation with § 1014 step-up — written for M&A counsel, transaction tax partners, investment-banking advisors, and owners diligencing a sale.

Executive summary

For a closely held C-corporation MSO, the exit mechanism may materially affect after-tax proceeds. A stock sale, asset sale, §338(h)(10) or §336(e) election, §1202-qualified stock sale, §1045 rollover, §368 reorganization, §331 liquidation, or hold-until-death strategy can produce very different results.

None of these paths should be assumed. Each depends on transaction-specific facts: entity status, buyer identity, shareholder basis, asset basis, holding period, original issuance records, gross assets, active-business use, state conformity, redemptions, installment terms, and final advisor reporting.

The purpose of this brief is to help deal teams identify which exit paths may be available early enough to preserve optionality.

What this brief does not say

• This brief does not say every C-corp MSO can qualify for §1202.
• It does not say §331 automatically preserves §1202 after an asset sale.
• It does not say a C-corp can directly access §338(h)(10).
• It does not say §336(e), §351, §368, §1045, or §1014 will produce any specific result.
• It does not say exit planning eliminates double tax.
• It does not provide a tax opinion, legal opinion, valuation conclusion, or transaction-specific reporting recommendation.

The narrower point is that a C-corp MSO may have several potential exit paths, and those paths should be evaluated early, documented carefully, and confirmed by transaction tax counsel at the time of the relevant transaction.

The stock-sale vs. asset-sale fight under § 1060

Every closely held M&A transaction begins with a structural tension that the parties resolve through price, indemnity, escrow, or election. Buyers want assets. Sellers want stock. The mechanics behind that preference are conceptually straightforward but fact-dependent, and they determine the entire negotiation.

In a straight asset sale, the corporation sells identified assets to the buyer. Under IRC § 1060, the parties allocate the purchase price across seven asset classes using the residual method, with goodwill in Class VII receiving the residual. The selling corporation recognizes gain at the corporate level on each asset; ordinary-income assets (depreciation recapture under § 1245, inventory under § 751-style principles, accounts receivable taxed as a cash-method seller would) drive a portion of the gain to ordinary rates, while goodwill is generally a capital asset. The corporation pays federal tax at 21% under § 11(b) plus state corporate tax. The shareholders then take the after-tax proceeds out as a liquidating distribution under § 331, recognizing a second layer of gain at the shareholder level — capital gain to the extent the distribution exceeds basis. Two tax layers, one transaction. This is the structural reason that closely held C-corp owners view asset sales as economically punitive.

In a stock sale, the shareholders sell their stock directly to the buyer. There is no transaction at the corporate level. Each shareholder recognizes capital gain equal to the difference between sale proceeds and adjusted stock basis — one tax layer, at long-term capital-gain rates (and potentially excluded entirely under § 1202 if the QSBS gating tests are met). The buyer takes the stock with a carryover basis in the underlying assets — meaning no step-up, no new depreciation, no amortization of acquired goodwill over 15 years under § 197. The buyer inherits all corporate liabilities, including contingent and unknown ones, mitigated only by indemnities and escrow.

The result: sellers prefer stock by a wide margin because it cuts one full tax layer out of the transaction. Buyers prefer assets because they get a stepped-up basis worth tens of millions in present-value tax shield over the 15-year § 197 amortization period, plus liability insulation. Where the buyer’s tax benefit from a step-up materially exceeds the seller’s incremental cost of double taxation, the parties typically resolve the disagreement by grossing up the purchase price — the buyer pays more in nominal terms to compensate the seller for the second tax layer. Where the buyer is a strategic that cannot use the step-up efficiently, or where the seller’s stock qualifies under § 1202 (eliminating the seller-side gain entirely), stock sales hold.

The § 1060 allocation fight inside an asset sale

Where an asset sale is the chosen structure, the negotiation moves from whether to how the price is allocated. Under IRC § 1060, both parties must use the residual method on IRS Form 8594. The buyer prefers allocation to short-lived depreciable assets (Class V, recoverable over 5–15 years) and to inventory (immediately deductible as cost of goods sold). The seller prefers allocation to goodwill (Class VII, long-term capital gain) and stock (Class IV equivalents). The parties’ allocations must agree under § 1060(b) — meaning the fight has to be resolved at signing, not later. A material disagreement post-close invites IRS scrutiny under the “consistent reporting” requirement.

§ 338(h)(10) and § 336(e) — the bridge between stock sale and asset sale

The U.S. tax code provides two elections that let parties document a transaction as a stock sale for non-tax purposes while treating it as an asset sale for federal tax purposes. They are IRC § 338(h)(10) and IRC § 336(e). For deal teams, these are the elections that resolve the stock-vs.-asset stalemate without forcing the buyer to inherit unknown corporate liabilities or the seller to retitle every contract, lease, and license.

§ 338(h)(10). Available when the seller is an S corporation or a corporate subsidiary that is part of a consolidated group, and the buyer is a corporation acquiring at least 80% of the target’s stock in a qualified stock purchase. Both parties make a joint election. For tax purposes, the target is treated as having sold all of its assets to a hypothetical “new target” for the deemed sales price (essentially the stock purchase price grossed up for liabilities), with the old target then liquidating. The seller recognizes the asset-level gain at the corporate level (or, in the S-corp case, at the shareholder level via pass-through) — usually a single tax layer. The buyer receives a stepped-up basis in the assets and the corresponding amortization and depreciation deductions going forward. The deal documents look like a stock purchase; the tax returns look like an asset sale.

§ 336(e). A close cousin made available later, covering situations where the buyer is not a corporation (e.g., an individual or a partnership) and § 338(h)(10) is therefore not available. The mechanics are similar; the election is made unilaterally by the seller (in the S-corp consolidated-group context) and the buyer takes a stepped-up basis. The election is principally useful in private-equity transactions where the acquiring PE fund holds the target through a pass-through vehicle.

A stand-alone C corporation generally cannot access § 338(h)(10) directly. If an S-election is considered before a future sale, the team must model the § 1374 built-in-gains recognition period, shareholder eligibility, state tax, timing, and whether the election creates other costs. Waiting out the five-year recognition period may reduce BIG-tax exposure, but the result depends on asset appreciation, timing, and final transaction structure.

Section 336(e) is not simply the "noncorporate buyer version" of § 338(h)(10). It applies only if the regulatory requirements for a qualified stock disposition and election are satisfied. The parties should confirm seller eligibility, target status, stock-disposition percentage, related-party rules, election procedures, and buyer structure before treating § 336(e) as available.

The § 1202 QSBS exclusion path

Where C-corporation MSO stock qualifies as QSBS under IRC § 1202 and a stock sale is commercially available, the stock-sale path may become materially more attractive than alternatives. After the One Big Beautiful Bill Act, Pub. L. No. 119–21, signed July 4, 2025, post-effective-date QSBS carries a per-issuer exclusion cap of $15 million or 10× the taxpayer’s aggregate adjusted basis — whichever is greater — on capital gain from the sale, after a five-year holding period. The full mechanics of the § 1202 gating tests are addressed in our companion brief on § 1202 QSBS through an MSO; this section focuses on how the exclusion functions as an exit path.

The exit-side mechanics are conceptually straightforward but fact-dependent where the gating tests are satisfied: the selling shareholder sells QSBS, reports the gain on Form 8949 and Schedule D, and excludes the eligible portion under § 1202(a) and (b). The gain is generally not subject to the 3.8% net investment income tax under § 1411 to the extent excluded. The result, in a clean qualifying transaction, is a federal tax rate on excluded gain of zero. State conformity varies; California, Pennsylvania, and several other states do not conform and tax the gain at full state rates.

Where the § 1202 path is on the table, three pre-exit moves matter:

• Stacking — ownership of the QSBS is allocated across multiple eligible taxpayers (founder, spouse, non-grantor trusts) before signing, each of whom receives an independent $15 million per-issuer cap, multiplying the family-group exclusion. Properly structured stacks can support $100 million+ of family-level exclusion.
• Packing — basis is added at original issuance through capital contributions of cash or appraised property, raising the 10×-basis side of the cap. A founder who contributes $5 million of basis at issuance supports a $50 million per-taxpayer cap, eclipsing the $15 million side.
• Asset-sale conversion via § 331 liquidation — where the buyer insists on an asset sale and the target’s stock would otherwise qualify under § 1202, sellers can have the corporation execute the asset sale, then complete a § 331 liquidation. The liquidating distribution to QSBS-holding shareholders is treated as a sale or exchange of the QSBS itself, preserving the § 1202 exclusion. In some cases, where the target stock otherwise qualifies as QSBS and the corporation completes a respected plan of complete liquidation, shareholders may evaluate whether the §331 exchange supports a §1202 position at the shareholder level. This does not eliminate corporate-level gain under §336 on the asset sale, and the sequence should be reviewed by transaction tax counsel before signing.

The § 1045 QSBS rollover path

Where QSBS is sold before the five-year holding period has run, IRC § 1045 provides a deferral mechanism that preserves the underlying QSBS character. A non-corporate taxpayer who sells QSBS held for more than six months may elect to defer recognition of the gain to the extent the proceeds are reinvested in other QSBS within 60 days of the sale. The deferred gain reduces the basis in the replacement QSBS; the holding period of the original stock tacks to the replacement under § 1045(b)(4).

The 60-day window is unforgiving. It runs from the date of sale, not the date of identification, and requires actual investment in QSBS of a different issuer that itself satisfies the gross-assets, active-business, and qualified-trade-or-business tests at the time of acquisition. A § 1045 rollover is principally useful in three scenarios:

• Early exit driven by external factors. A strategic acquirer surfaces at year three or four and the seller is unwilling to walk away from the offer to wait out the five-year clock. Rollover preserves optionality on future QSBS treatment.
• Partial early monetization. The shareholder sells a tranche before five years to fund liquidity needs and rolls the proceeds into a new QSBS investment, preserving the federal exclusion architecture on the broader position.
• Portfolio rebalancing inside a family office. A family office that holds QSBS positions across multiple operating companies can use § 1045 to redeploy capital from one QSBS issuer to another without recognizing gain, treating the family-office QSBS allocation as a single tax-deferred pool.

After OBBBA, the § 1045 rollover has been partially relieved by the new tiered exclusion at § 1202(a)(5): a seller at year three or four now gets a partial exclusion (50% or 75%) outright on post-July-4-2025 QSBS, reducing the urgency of the rollover for early exits. But for pre-OBBBA stock still on the five-year cliff, and for sales at less than three years, § 1045 remains the only tool that preserves QSBS character before maturity.

§ 351 contributions in pre-exit restructuring

Most exit-stage tax planning is conducted on the eve of a transaction, but the structural moves that produce the cleanest exits are made years earlier. IRC § 351 is the core tool. It permits the tax-free contribution of property to a corporation in exchange for stock where the contributing shareholders — immediately after the transfer — control 80% or more of the corporation as defined in § 368(c).

For exit planning, the typical use cases are:

• MSO formation. A founder contributes intellectual property, contracts, software, or a book of management business into a newly formed MSO C-corporation in exchange for QSBS-eligible stock. The contribution is tax-free under § 351 if the control test is satisfied, the basis of the contributed property carries over to the stock under § 358, and the corporation takes a carryover basis in the contributed property under § 362. From that moment, the five-year QSBS clock starts running.
• Pre-roll-up consolidation. Multiple operating entities are contributed into a holding C-corp under § 351 in exchange for stock, creating a single saleable platform without triggering gain on the contributing entities. Particularly useful where the planned exit is a strategic sale of the consolidated platform 18–36 months later.
• Spin-out preparation. A non-core line of business is contributed into a new subsidiary under § 351, then distributed to shareholders under § 355 as a tax-free spin-off, separating the saleable asset from the operating company.

The § 351 path is unavailable when the contributing shareholders do not collectively control the receiving corporation after the transfer (the “control immediately after” test), when the contributed property is encumbered with liabilities exceeding basis (potential gain under § 357(c)), or when services are exchanged for stock (services contributors are excluded from the § 368(c) control group). Each of these traps is fact-specific and survivable with proper structuring.

Contributions of services do not qualify as property for § 351 control purposes, and contributed intangibles, contracts, goodwill, or customer relationships need valuation, transferability review, assignment consent, basis analysis, and business-purpose support. If the contributed asset is personal goodwill, professional goodwill, or regulated-practice goodwill, counsel should confirm who owns it and whether it can be transferred.

§ 368 tax-free reorganizations

Where the exit involves another corporation as the acquirer — whether a strategic buyer or a public company — IRC § 368 provides a menu of reorganization patterns under which the transaction is treated as tax-free, in whole or in part, at both the corporate and shareholder levels. The principal patterns:

• Type A reorganization — statutory merger (§ 368(a)(1)(A)). The target merges into the acquirer under state corporate law. Target shareholders receive acquirer stock and optionally cash or other property (“boot”). To the extent consideration is acquirer stock, no gain is recognized; boot triggers gain to the extent received, capped at the realized gain. The standard structure for public-company stock-for-stock acquisitions of closely held targets.
• Type B reorganization — stock-for-stock (§ 368(a)(1)(B)). The acquirer exchanges its own voting stock solely for stock of the target, gaining control (80% under § 368(c)) of the target. Solely is strict — any boot disqualifies the entire transaction. Target shareholders defer all gain; the acquirer takes a carryover basis in the target stock. Useful where the acquirer wants to keep the target as a subsidiary and the parties can accept a pure stock deal.
• Type C reorganization — asset-for-stock (§ 368(a)(1)(C)). The acquirer exchanges its voting stock for substantially all of the target’s assets, after which the target liquidates and distributes the acquirer stock to its shareholders. Limited boot is permitted but reduces the tax-free portion. The standard structure when the acquirer wants the assets but the parties prefer reorganization treatment over a taxable asset sale.
• Type D reorganization — divisive (§ 368(a)(1)(D)). Combined with a § 355 distribution, used to spin off, split off, or split up a corporation tax-free. Standard architecture for pre-sale carve-outs.
• Type F reorganization — mere change in form (§ 368(a)(1)(F)). A pure change in identity, form, or place of organization — e.g., reincorporating in Delaware, converting a state-law LLC to a state-law C-corp without changing economic ownership. Tax-free; preserves attribute carryover including the QSBS clock in many cases.

Reorganization treatment requires continuity of interest (target shareholders must retain a substantial proprietary interest in the acquirer, generally measured at ≥40% stock consideration), continuity of business enterprise (the acquirer must continue the target’s historic business or use a significant portion of its assets), and a business purpose beyond tax avoidance. Each requirement is independently litigable and is the source of most reorganization disputes.

Complete liquidation under § 331 and the § 1014 basis step-up — the no-sale exit

Not every C-corp exit involves a third-party sale. For shareholders who do not need liquidity, the most tax-efficient exit is often not exiting during life. IRC § 1014 provides that property acquired from a decedent receives a new basis equal to fair market value at the date of death. The capital gain that accrued during the decedent’s life is may be eliminated for income-tax purposes through a basis adjustment, subject to estate tax and applicable law for income tax purposes — though the asset remains subject to federal estate tax under § 2001.

The concept is simple, but the implementation depends on estate tax exposure, liquidity needs, control, valuation, and governance: hold the C-corp stock until death, take the § 1014 step-up, and have the heirs sell with little or no income-tax gain. Where the family also wants ongoing income, the MSO continues operating as a corporate family-office wrapper post-death, generating fee income that is taxed at the 21% corporate rate under § 11(b) and distributed (or not) on the timing the family prefers.

Where liquidation during life is required — the business is winding down, the family wants to extract cash without a buyer, or QSBS treatment is being preserved on an asset-sale buyer — IRC § 331(a) governs. The shareholder treats the liquidating distribution as full payment in exchange for the stock, recognizing capital gain (or loss) on the difference between distribution and stock basis. The corporation recognizes gain on the deemed sale of its assets at the corporate level under § 336 — producing the same double-tax stack as an asset sale unless QSBS exclusion applies at the shareholder level. IRC § 332 is the parallel rule for liquidation of an 80%-owned subsidiary into its parent, which is tax-free at both levels.

The procedural requirement under § 331: the corporation must adopt a formal plan of complete liquidation by board resolution, file IRS Form 966 within 30 days of adoption, and complete the distributions within 24 months (longer periods are permitted with cause). The plan is the documentary anchor for § 331 treatment and is the first thing the IRS asks for on examination.

Law-firm MSO application

In law-firm MSO planning, the exit analysis is different from a generic C-corporation sale. The law firm's legal practice generally must remain attorney-owned in jurisdictions that restrict non-lawyer ownership. The potentially saleable asset is the non-legal service platform: finance, accounting, HR, marketing, intake, billing, collections, technology, vendor management, real estate, reporting, and administrative infrastructure.

Any exit path should be reviewed with legal-ethics counsel, transaction tax counsel, and M&A counsel. The analysis should distinguish the law practice, the non-legal MSO service platform, personal goodwill, firm goodwill, IP, rollover equity, earn-outs, and continuing service compensation. See our companion brief on law-firm MSOs in private equity for more on the platform side.

Side-by-side after-tax comparison (illustrative)

The five strategic exit paths produce materially different after-tax outcomes at the same headline deal size. The matrix below compares a hypothetical $50 million C-corp transaction across the principal paths, assuming a single individual shareholder with $0 stock basis and ignoring state tax. These figures are illustrative only and depend entirely on facts that vary across transactions.

After-tax proceeds sensitivity across deal sizes

The relative advantage of each exit path scales non-linearly with deal size. The § 1202 path may produce a materially better after-tax result at deal sizes up to the per-issuer cap, where available ($15 million per taxpayer post-OBBBA, or 10× basis where higher); beyond that ceiling, the marginal exclusion drops to zero and the analysis pivots to whether stacking across multiple eligible taxpayers can extend the exclusion. The § 338(h)(10) and asset-sale paths remain available across all deal sizes but require a corporate-level tax layer unless the seller can convert to S-corp status and wait out the BIG-tax window. The § 368 reorganization path is consideration-mix dependent — gain is recognized to the extent of boot received.

Installment sales under § 453: spreading recognition

Where the parties cannot agree on price or where the seller wants to manage recognition across multiple tax years, IRC § 453 permits installment-method reporting on the sale of stock or property. The seller recognizes gain proportionally as principal payments are received, deferring recognition over the payment schedule. Imputed interest at the applicable federal rate under § 1274 attaches to the deferred balance; sub-AFR notes trigger original-issue-discount recharacterization under § 483.

Installment treatment is unavailable for publicly traded securities, for certain dealer dispositions, and (importantly) does not avoid built-in-gains tax in the S-corp context under Treas. Reg. § 1.1374-4(h). Where QSBS is being sold on installment, the shareholder can elect out of § 453 to accelerate recognition into the year of sale and lock in the § 1202 exclusion before the tax landscape changes.

Disclosures

This brief is general information for institutional and professional audiences and does not constitute tax, legal, accounting, or investment advice. It is not a covered opinion under Circular 230 and may not be relied upon for the purpose of avoiding any penalty that may be imposed under the Internal Revenue Code. The Internal Revenue Code sections cited reflect the general legal framework as of the date of publication; application to any specific transaction is fact-specific and depends on entity status, basis, holding period, counterparty status, state conformity, and structural details that vary across deals. The illustrative dollar figures in Figures 1, 3, and 4 are stylized for comparative purposes and do not represent any actual transaction or outcome. Section 1202 qualification, § 1045 rollover availability, § 338(h)(10) election availability, and § 368 reorganization treatment each depend on independent gating tests that must be diligenced on facts at signing. Private letter rulings are nonprecedential under IRC § 6110(k)(3). Readers should consult qualified tax counsel and a transaction tax accountant before relying on any of the structures discussed.

Frequently asked questions

Why do buyers prefer asset sales and sellers prefer stock sales?

Buyers prefer asset sales because they obtain a stepped-up basis in acquired assets, generating future depreciation and 15-year amortization of goodwill under IRC § 197 — a present-value tax shield often worth 10–25% of the purchase price. They also escape unknown corporate liabilities. Sellers prefer stock sales because they pay one layer of tax (capital gain at the shareholder level) instead of two (corporate-level gain on the assets, then shareholder-level gain on the liquidating distribution). The parties typically resolve the gap with a price gross-up or a § 338(h)(10) election.

Can a C-corporation shareholder ever access the § 338(h)(10) election?

Not directly. § 338(h)(10) requires the seller to be an S corporation or a corporate subsidiary in a consolidated/affiliated group. A C-corp shareholder considering an exit several years out can convert to S-corp status, then wait out the five-year recognition period for built-in-gains tax under Treas. Reg. § 1.1374-4(h) before signing a § 338(h)(10) transaction. The lead time is real but the after-tax benefit can be substantial.

How does § 1202 interact with the § 1014 step-up at death?

Both eliminate income tax on the same accrued gain; they are alternatives, not complements. Where the shareholder is willing and able to hold the QSBS until death, the § 1014 step-up eliminates all unrealized gain (including gain in excess of the § 1202 per-issuer cap) at the cost of the stock remaining in the gross estate under § 2001. Where the shareholder wants liquidity during life, § 1202 produces a tax-free or near-potentially tax-advantaged exit up to the per-issuer cap, and a stack across multiple taxpayers multiplies the available exclusion. Many families do both: hold a portion of the QSBS until death for § 1014 treatment, sell a portion during life under § 1202.

What is the 60-day § 1045 window measured from?

The 60-day rollover period under IRC § 1045(a) runs from the date of sale of the original QSBS, not the date the seller identifies the replacement QSBS. The seller must actually invest in the replacement QSBS within 60 days — in cash — and the replacement issuer must satisfy the QSBS gating tests at the time the replacement stock is acquired. Operationally, this requires either having a replacement target identified before the sale closes or being willing to make the rollover investment under time pressure.

Can a § 331 liquidation support a § 1202 position after an asset sale?

Potentially, but only if the target stock otherwise qualifies as QSBS and the liquidation is respected as a complete liquidation under § 331. Section 1202 may apply to the shareholder-level exchange of qualifying stock, but it does not eliminate corporate-level gain recognized by the C corporation on the asset sale under § 336. The sequence, plan of liquidation, Form 966 filing, timing of distributions, escrow or installment mechanics, and shareholder reporting position should be reviewed by transaction tax counsel.

What is the difference between § 338(h)(10) and § 336(e)?

Both elections allow a stock-form transaction to be treated as an asset-form transaction for federal tax purposes. The principal difference is the identity of the buyer. § 338(h)(10) requires a corporate buyer that makes a qualified stock purchase of at least 80% of the target. § 336(e) may be available if the statutory requirements are satisfied and the buyer is not a corporation — most commonly when the acquirer is a private-equity fund holding the target through a partnership or LLC. The mechanics are otherwise similar; § 338(h)(10) is a joint election by buyer and seller, while § 336(e) is made unilaterally by the seller (subject to consolidated-group rules).

Can a § 368 tax-free reorganization be combined with cash consideration?

Yes, with limits that vary by reorganization type. Type A statutory mergers and Type C asset-for-stock reorganizations permit limited “boot” (cash or other non-stock consideration) so long as the continuity-of-interest requirement is satisfied — generally measured at ≥40% stock consideration. Boot triggers gain recognition to the recipient shareholders to the extent of the boot received, capped at realized gain. Type B stock-for-stock reorganizations are strict: any boot disqualifies the entire transaction. Type F reorganizations admit no boot by definition (mere change in form).

What is § 1060 and why does it matter in an asset sale?

IRC § 1060 governs the allocation of purchase price across asset classes in an applicable asset acquisition (which includes most asset deals and § 338(h)(10) transactions). The buyer and seller must use the residual method and file consistent IRS Forms 8594. The allocation matters because different asset classes generate different tax characters: ordinary income on depreciation recapture and inventory, long-term capital gain on goodwill, ordinary income on covenants not to compete. Buyers prefer allocations to short-lived depreciable assets; sellers prefer allocations to goodwill. The allocation has to be negotiated and documented at signing because of the consistent-reporting requirement.

How does an installment sale under § 453 interact with § 1202 exclusion?

Installment treatment defers recognition of gain over the payment schedule. For QSBS sellers, this is often counterproductive — deferring recognition means deferring the § 1202 exclusion benefit, leaving the seller exposed to legislative risk that § 1202 itself could be amended or repealed in a future year. Most QSBS sellers elect out of § 453 under § 453(d), accelerating all recognition into the year of sale and locking in the exclusion at then-current law.

How early should exit planning start?

Earlier than most owners expect. The QSBS five-year clock starts at issuance; the S-corp conversion BIG-tax window is five years; pre-exit § 351 contributions and § 368(F) reorganizations need to settle 12–18 months before signing to avoid step-transaction recharacterization risk. The optimization windows for the highest-value exit paths all close at or before the signing of a definitive agreement. A reasonable rule of thumb: serious exit-path planning starts five years before the contemplated transaction, refines at three years, locks the structure at 18 months, and runs after-tax models at signing.